Uloga inhibitora Src tirozin-kinaze u prevazilaženju urođeno rezistentnog i invazivnog fenotipa glioblastoma

Doktorand: Nešović, Marija D.
Fakultet: Biološki fakultet
Napomena: Rok za dostavljanje primedbi na doktorsku disertaciju je istekao.
Datum postavljanja na uvid javnosti: 29-09-2021
Datum odbrane: 14-12-2021
Objavljeni radovi:
[1]  Nešović M, Divac Rankov A, Podolski-Renić A, Nikolić I, Tasić G, Mancini A, Schenone S, Pešić M, Dinić J. Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo. Cancers (Basel). 2020 Jun 14;12(6):1570. doi: 10.3390/cancers12061570. https://www.mdpi.com/2072-6694/12/6/1570 M21
[2]  Fallacara AL, Zamperini C, Podolski-Renić A, Dinić J, Stanković T, Stepanović M, Mancini A, Rango E, Iovenitti G, Molinari A, Bugli F, Sanguinetti M, Torelli R, Martini M, Maccari L, Valoti M, Dreassi E, Botta M, Pešić M, Schenone S. A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor. Cancers (Basel). 2019 Jun 19;11(6):848. doi: 10.3390/cancers11060848. https://www.mdpi.com/2072-6694/11/6/848 M21